<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9(6)</volume><submitter>Hu Q</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>To retrospectively evaluate the therapeutic effectiveness and safety of flexible ureteroscopes without preoperative ureteral stent placement.&lt;h4>Methods&lt;/h4>A total of 243 patients who had undergone flexible ureteroscopy (fURS) lithotripsy were reviewed. The patients were divided into two groups: 119 patients without preoperative ureteral stent placement were set as group A; and the remaining 124 patients who received preoperative ureteral stent placement were set as group B. The operative time, length of hospital stay, hospital costs, stone-free rates (SFRs), complications, and re-operation rates of the two groups were respectively compared.&lt;h4>Results&lt;/h4>Pairwise analysis indicated the following: the average operative time of group A was longer than that of group B (66.53±10.19 versus 59.85±9.85 min, P=0.0001), the average length of hospital stay of group A was considerably shorter than that of group B (6.56±0.90 versus 10.67±1.50 d, P=0.0001), the SFRs of group A were significantly lower than those of group B at 3 days postoperatively (36.1%, 43/119 versus 51.6%, 64/124, P=0.0034), and the average hospital costs were substantially lower in group A than those in group B (18,756 versus 23,450 RMB, P=0.0001). However, there were no notable differences observed in the following: SFRs between the groups at 1 month postoperatively (84.0%, 100/119 of group A versus 85.5%, 106/124 of group B, P=0.895), complications rates (20.1%, 26/124 in group A versus 20.1%, 23/114 in group B, P=0.597), and re-operation rates (15.1%, 18/119 in group A versus 16.9%, 21/124 in group B, P=0.558).&lt;h4>Conclusions&lt;/h4>These results indicated that fURS without preoperative ureteral stent placement is safe and effective for the treatment of upper urinary calculi.</pubmed_abstract><journal>Translational andrology and urology</journal><pagination>2723-2729</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7807313</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Is a ureteral stent required before flexible ureteroscopy?</pubmed_title><pmcid>PMC7807313</pmcid><pubmed_authors>Lai Y</pubmed_authors><pubmed_authors>Zhang J</pubmed_authors><pubmed_authors>Liang H</pubmed_authors><pubmed_authors>Deng Q</pubmed_authors><pubmed_authors>Ji Y</pubmed_authors><pubmed_authors>Wang H</pubmed_authors><pubmed_authors>Hu Q</pubmed_authors><pubmed_authors>Wang Z</pubmed_authors><pubmed_authors>Zhao H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Is a ureteral stent required before flexible ureteroscopy?</name><description>&lt;h4>Background&lt;/h4>To retrospectively evaluate the therapeutic effectiveness and safety of flexible ureteroscopes without preoperative ureteral stent placement.&lt;h4>Methods&lt;/h4>A total of 243 patients who had undergone flexible ureteroscopy (fURS) lithotripsy were reviewed. The patients were divided into two groups: 119 patients without preoperative ureteral stent placement were set as group A; and the remaining 124 patients who received preoperative ureteral stent placement were set as group B. The operative time, length of hospital stay, hospital costs, stone-free rates (SFRs), complications, and re-operation rates of the two groups were respectively compared.&lt;h4>Results&lt;/h4>Pairwise analysis indicated the following: the average operative time of group A was longer than that of group B (66.53±10.19 versus 59.85±9.85 min, P=0.0001), the average length of hospital stay of group A was considerably shorter than that of group B (6.56±0.90 versus 10.67±1.50 d, P=0.0001), the SFRs of group A were significantly lower than those of group B at 3 days postoperatively (36.1%, 43/119 versus 51.6%, 64/124, P=0.0034), and the average hospital costs were substantially lower in group A than those in group B (18,756 versus 23,450 RMB, P=0.0001). However, there were no notable differences observed in the following: SFRs between the groups at 1 month postoperatively (84.0%, 100/119 of group A versus 85.5%, 106/124 of group B, P=0.895), complications rates (20.1%, 26/124 in group A versus 20.1%, 23/114 in group B, P=0.597), and re-operation rates (15.1%, 18/119 in group A versus 16.9%, 21/124 in group B, P=0.558).&lt;h4>Conclusions&lt;/h4>These results indicated that fURS without preoperative ureteral stent placement is safe and effective for the treatment of upper urinary calculi.</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Dec</publication><modification>2025-04-26T18:27:22.778Z</modification><creation>2025-02-19T01:41:24.082Z</creation></dates><accession>S-EPMC7807313</accession><cross_references><pubmed>33457244</pubmed><doi>10.21037/tau-20-1458</doi></cross_references></HashMap>